Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.37204 | 14 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.33288 | 13 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.33216 | 13 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.28195 | 13 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.27977 | 13 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.39976 | 14 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.36333 | 14 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.30917 | 13 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.3044 | 13 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.32094 | 13 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.32716 | 14 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.31026 | 13 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.33112 | 13 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.3282 | 13 |